Vitura Health Limited (ASX:VIT)
Australia · Delayed Price · Currency is AUD 0.0200
-0.0010 (-4.76%)
Sep 11, 2026, 10:22 AM AEST
Vitura Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 131.16 | 124.04 | 123.87 | 117.34 | 66.99 |
| 131.16 | 124.04 | 123.87 | 117.34 | 66.99 | |
Revenue Growth | 5.74% | 0.13% | 5.56% | 75.16% | 208.54% |
Cost of Revenue | 102.71 | 90.29 | 89.65 | 77.65 | 41.56 |
Gross Profit | 28.45 | 33.75 | 34.22 | 39.69 | 25.43 |
Selling, General & Admin | 30.46 | 28.51 | 29.35 | 19.83 | 15.51 |
Operating Expenses | 30.46 | 28.51 | 29.35 | 19.83 | 15.51 |
Operating Income | -2.01 | 5.24 | 4.87 | 19.86 | 9.92 |
Interest Expense | -0.93 | -1.08 | -0.65 | -0.03 | -0.06 |
Interest & Investment Income | 0.39 | 0.43 | 0.67 | 0.33 | 0.01 |
Currency Exchange Gain (Loss) | -0.12 | 0.08 | -0.18 | -0.06 | -0.2 |
Other Non Operating Income (Expenses) | -0.74 | -0.03 | -0.15 | -0.06 | -0.15 |
EBT Excluding Unusual Items | -3.41 | 4.65 | 4.56 | 20.04 | 9.52 |
Impairment of Goodwill | -1.63 | - | - | - | - |
Gain (Loss) on Sale of Investments | -0.27 | 0.04 | - | 0.01 | - |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0 | 0.01 | 0.22 |
Pretax Income | -5.29 | 4.71 | 4.56 | 20.05 | 9.74 |
Income Tax Expense | -0.89 | 1.64 | 1.31 | 6.3 | 3.73 |
Earnings From Continuing Operations | -4.41 | 3.06 | 3.25 | 13.75 | 6.01 |
Minority Interest in Earnings | 0.01 | 0.26 | 0.26 | 0.06 | 0.04 |
Net Income | -4.39 | 3.32 | 3.51 | 13.81 | 6.05 |
Net Income to Common | -4.39 | 3.32 | 3.51 | 13.81 | 6.05 |
Net Income Growth | - | -5.35% | -74.56% | 128.31% | 326.72% |
Shares Outstanding (Basic) | 663 | 610 | 570 | 555 | 482 |
Shares Outstanding (Diluted) | 663 | 610 | 570 | 572 | 487 |
Shares Change | 8.65% | 7.01% | -0.33% | 17.44% | 21.21% |
EPS (Basic) | -0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
EPS (Diluted) | -0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
EPS Growth | - | -11.55% | -74.54% | 95.15% | 254.39% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -0.22 | 2.58 | 6.67 | 8.78 | 13.14 |
Free Cash Flow Per Share | - | 0.00 | 0.01 | 0.01 | 0.03 |
Dividend Per Share | - | 0.002 | - | 0.010 | 0.010 |
Dividend Growth | - | - | - | 0% | - |
Gross Margin | 21.69% | 27.21% | 27.63% | 33.82% | 37.96% |
Operating Margin | -1.53% | 4.23% | 3.93% | 16.93% | 14.81% |
Profit Margin | -3.35% | 2.68% | 2.84% | 11.77% | 9.03% |
Free Cash Flow Margin | -0.17% | 2.08% | 5.38% | 7.48% | 19.61% |
EBITDA | -1.69 | 6.73 | 5.78 | 20.22 | 10.12 |
EBITDA Margin | -1.29% | 5.42% | 4.67% | 17.23% | 15.11% |
D&A For EBITDA | 0.32 | 1.48 | 0.91 | 0.36 | 0.2 |
EBIT | -2.01 | 5.24 | 4.87 | 19.86 | 9.92 |
EBIT Margin | -1.53% | 4.23% | 3.93% | 16.93% | 14.81% |
Effective Tax Rate | - | 34.93% | 28.79% | 31.44% | 38.30% |